Abiraterone In Metastatic Prostate Cancer

Abiraterone in Metastatic Prostate Cancer

Abiraterone in metastatic castration-sensitive prostate cancer

Dr. Graff on the Use of Abiraterone in Metastatic Prostate Cancer

Abiraterone for metastatic, hormone sensitive, prostate cancer

Abiraterone vs docetaxel for metastatic castrate resistant prostate cancer

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Quality of Life and Survival with Abiraterone in Advanced Prostate Cancer

Prostate Cancer: Unlock the Secrets to Prevention Before It’s Too Late!

Prioritized Health

Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC

"Abiraterone saved my life." | Alfred's prostate cancer story

The Institute of Cancer Research, London

LATITUDE supports first-line abiraterone use for metastatic prostate cancer | Kim Chi

Medicine Matters oncology

Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223

Grand Rounds in Urology

Who should get abiraterone in non-metastatic prostate cancer?

OncBrothers: Practice-Changing Cancer Discussions

Dr. Chi on Abiraterone Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer

Dr. Mark Scholz on Using Abiraterone in mCRPC

Prostate cancer: Abiraterone for progressive metastatic disease

Gerald Chodak MD

Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer

Dr. Bryce on the Use of Abiraterone Versus Docetaxel in Patients With Prostate Cancer

Dr. Oh Discusses the Use of Abiraterone and Docetaxel in Prostate Cancer

Targeted Oncology

Dr. Burgess on the Synergy Between Abiraterone and ADT in Prostate Cancer